DCA and CancerDCA as a Cancer Treatment - Sodium Dichloroacetate


The Michelakis European DCA Patent application appears to have been withdrawn.


I am told by a knowledgeable source "The conclusions were that it did not [meet] the standards of patentability and novelty because of previous publication." See below for reasons given.


DCA patent abandoned


michelakis patent 1

michelakis patent 1

michelakis patent 3